Status: Recruiting
VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization
Venous thromboembolism (VTE) has a high prevalence in patients with multiple comorbidities undergoing complex surgical procedures. Sometimes, extended prophylaxis for VTE with KLMWH or direct oral anticoagulants (DOACs) is necessary. Currently, there is no consensus in the literature regarding the use of DOACs for extended VTE prophylaxis in patients undergoing lower limb revascularization (LLR). Objective: To evaluate the use of DOACs (already approved to reduce MACE and MALE) in VTE prophylaxis in patients undergoing LLR.
Participants needed: 100
Trial details
Phase: Phase 4Biological sex: AllType: InterventionalSponsor: Science Valley Research InstituteUpdated: Mar 12, 2025Locations: 1
Eligibility criteria
Be adults of any age and gender. [+2]
Experience a symptomatic VTE event during hospitalization, as they will require... [+2]